Exposure to ozone pollution is associated with increased CVS-related hospitalizations

Published Date: 13 Mar 2023

Researchers have found in a new study that exposure to ozone pollution can increase the number of hospitalizations associated with heart disease. Also...

Read Full News

Latest News

Treat the Overlap Between Long COVID and Chronic Fatigue

As more patients seek help for myalgic encephalomyelitis/chronic fatigue syndrome and similar symptoms for long COVID, primary care clinicians play a bigger role in treatment.

Higher Abdominal Fat Linked to Faster Biological Aging

Higher abdominal fat is associated with accelerated biological aging across multiple measures, and metabolic aging explains much of the increased risks for heart disease and death.

Nighttime BP Measured Using Wrist Device Reveals Heart Risks

Nighttime blood pressure measured at home with a wrist-worn device is independently associated with the odds of left ventricular hypertrophy, beyond office and morning measurements.

Does Obesity Drive Related Conditions in Older Adults?

Many health conditions related to obesity are common in older adults, but some are more attributable to obesity than others.

Beyond the Mediterranean Diet: What’s Next for Gut Health?

Emerging data suggest Western dietary patterns may promote inflammatory gut changes, whereas traditional diets appear linked to more favorable metabolic effects.

Add-On Alteplase May Aid Stroke Recovery Post-Thrombectomy

Adjunctive intra-arterial alteplase after successful thrombectomy may aid functional recovery compared to thrombectomy alone in large vessel occlusion stroke, new data show.

Todays Updates

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Todays Updates

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Latest News

As more patients seek help for myalgic encephalomyelitis/chronic fatigue syndrome and similar symptoms for long COVID, primary care clinicians play a bigger role in treatment.

Higher abdominal fat is associated with accelerated biological aging across multiple measures, and metabolic aging explains much of the increased risks for heart disease and death.

Nighttime blood pressure measured at home with a wrist-worn device is independently associated with the odds of left ventricular hypertrophy, beyond office and morning measurements.

Many health conditions related to obesity are common in older adults, but some are more attributable to obesity than others.

Emerging data suggest Western dietary patterns may promote inflammatory gut changes, whereas traditional diets appear linked to more favorable metabolic effects.

Adjunctive intra-arterial alteplase after successful thrombectomy may aid functional recovery compared to thrombectomy alone in large vessel occlusion stroke, new data show.

News All Time

Drug Options for Three High-Risk Prediabetes Types

Identifying three high-risk prediabetes types can help physicians decide when to add metformin, GLP-1/GIP agents, or SGLT2 inhibitors to lifestyle care.

Increased Mortality After Radiotherapy for Pituitary Adenoma

Patients with pituitary adenomas who receive radiotherapy with or without surgery have a higher rate of long-term mortality than the general population, largely due to cerebrovascular disease.

EMA Backs Options for Broadening Obesity Care in Europe

EMA has recommended Ablymico and Liraglutide STADA and an oral formulation of Wegovy, potentially expanding GLP-1 treatment options for diabetes and weight management across Europe.

EU Supports Anti-Inflammatory for Secondary Heart Risk

The European Medicine Agency has recommended marketing authorization for a hybrid colchicine medicine for secondary prevention of atherothrombotic events in adults with stable coronary disease.

Cooling Vest May Reduce Body Fat in Obesity

Wearing a cooling vest for a few hours each morning may aid weight loss and reduce fat mass in adults with overweight or obesity.

Does Cardiovascular Disease Diagnosis Increase Cancer Risk?

A prospective study shows that the diagnosis of cardiovascular disease is associated with an increase in the risk for cancer within the first year, especially in women.

Early Ablation Cuts Serious Heart Risks in Patients With AF

Catheter ablation within a year of diagnosis of atrial fibrillation is linked to reduced risks for major adverse cardiovascular events, heart failure, and all-cause mortality in high-risk patients.

The Fastest Way to Better Anticoagulants May Be a Land Snail

Researchers have identified a compound produced by a variety of land snail that prevents blood clots without prolonging bleeding or healing time.

Exercise Plus Diet Lowers Leptin in Hypertensive Obesity

A 16-week supervised aerobic exercise program combined with a hypocaloric diet reduces leptin levels in adults with hypertension and overweight or obesity.

Loop Recorders Reveal Arrhythmias in Cardiac Amyloidosis

In patients with cardiac amyloidosis, implantable loop recorders reveal common yet often silent arrhythmias that vary by disease subtype and are linked to amyloid buildup in the heart muscle.

Airway Thickness on qCT Signals Heart Dysfunction in COPD

Routine quantitative CT scans performed during acute COPD exacerbations can reveal undiagnosed cardiac dysfunction, with increased airway wall thickness signalling impaired left ventricular function.

Gene Editing: A ‘One-Time’ Treatment for CVD?

Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will take years.

Baxdrostat Approval May Open Doors for HTN Therapy

The FDA’s recent approval of baxdrostat may usher in new possibilities for treatment for uncontrolled hypertension.

Lentigo Maligna Rarely Progresses Despite Rising Incidence

Despite rising cases in recent years, lentigo maligna shows minimal progression to melanoma, and patients with this condition are more likely to die due to other factors, a retrospective study finds.

Eating for One: The Future of Personalized Nutrition

Nutrition science is closing in on truly personalized dietary advice. The bigger challenge? Making sure it does not only land on wealthy plates.

Prior Auth Rules Vary Widely Across Insurers, Study Finds

A new study finds that prior authorization requirements vary widely across major insurers and suggests large language models could help streamline how authorization rules are interpreted and processed.

Recommended News For You

Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024

Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

combating racial discrimination in next-generation breast cancer screening.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Renewing the call for a national Cancer Patient's Bill of Rights

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

Recommended Articles For You

CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies 

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide 

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

2.

Breast cancer prevention: How nurse practitioners and physician assistants can help

3.

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

4.

Liver cancer survival rates reflect income disparities

5.

In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.

1.

Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research

2.

The Miracle of Tenecteplase: How This Drug Is Saving Lives

3.

The Importance of Iron Rich Foods in Preventing and Treating Anemia 

4.

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights

5.

The Science Behind Imatinib: How It Targets Cancer Cells 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

3.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

5.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot